Kaleido Biosciences Raises $101 Million Series C Financing

Kaleido Biosciences Raises $101 Million Series C Financing

Source: 
CP Wire
snippet: 

Kaleido Biosciences, announced on 6/25/2018 that it has closed $101 million in an oversubscribed Series C financing. Several new investors participated in the financing, including a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), Fidelity Management and Research Company, Invus, and Rock Springs Capital, along with Kaleido’s founder, Flagship Pioneering, and a number of undisclosed investors.